HEADER TRANSFERASE 01-DEC-03 1RO7 TITLE STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM CAMPYLOBACTER TITLE 2 JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOGUE, CMP-3FNEUAC. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-2,3/8-SIALYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 2.4.99.-; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI; SOURCE 3 ORGANISM_TAXID: 197; SOURCE 4 GENE: CST; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET41A KEYWDS MIXED ALPHA/BETA, ROSSMANN FOLD, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.P.CHIU,A.G.WATTS,L.L.LAIRSON,M.GILBERT,D.LIM,W.W.WAKARCHUK, AUTHOR 2 S.G.WITHERS,N.C.STRYNADKA REVDAT 4 27-OCT-21 1RO7 1 REMARK SEQADV LINK REVDAT 3 31-JAN-18 1RO7 1 REMARK REVDAT 2 24-FEB-09 1RO7 1 VERSN REVDAT 1 03-FEB-04 1RO7 0 JRNL AUTH C.P.CHIU,A.G.WATTS,L.L.LAIRSON,M.GILBERT,D.LIM, JRNL AUTH 2 W.W.WAKARCHUK,S.G.WITHERS,N.C.STRYNADKA JRNL TITL STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM JRNL TITL 2 CAMPYLOBACTER JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOG. JRNL REF NAT.STRUCT.MOL.BIOL. V. 11 163 2004 JRNL REFN ISSN 1545-9993 JRNL PMID 14730352 JRNL DOI 10.1038/NSMB720 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1876668.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 99667 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5034 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 15501 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 855 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8162 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 176 REMARK 3 SOLVENT ATOMS : 330 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.23000 REMARK 3 B22 (A**2) : 5.33000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.78000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.660 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 41.01 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIGAND.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : &_1_TOPOLOGY_INFILE_2 REMARK 3 TOPOLOGY FILE 3 : &_1_TOPOLOGY_INFILE_3 REMARK 3 TOPOLOGY FILE 4 : &_1_TOPOLOGY_INFILE_4 REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000020910. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 99748 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : 23.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.52600 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 2000, SODIUM CHLORIDE, BICINE, REMARK 280 PH 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 18K, REMARK 280 TEMPERATURE 291.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.01550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 259 REMARK 465 TYR B 156 REMARK 465 GLN B 157 REMARK 465 ASN B 158 REMARK 465 GLY B 159 REMARK 465 SER B 160 REMARK 465 SER B 161 REMARK 465 TYR B 162 REMARK 465 ALA B 163 REMARK 465 PHE B 164 REMARK 465 ASP B 165 REMARK 465 THR B 166 REMARK 465 LYS B 167 REMARK 465 LYS B 179 REMARK 465 ASN B 180 REMARK 465 ASP B 181 REMARK 465 ASN B 182 REMARK 465 SER B 183 REMARK 465 HIS B 184 REMARK 465 TYR B 185 REMARK 465 ILE B 186 REMARK 465 GLY B 187 REMARK 465 ASN B 259 REMARK 465 GLN C 157 REMARK 465 ASN C 158 REMARK 465 GLY C 159 REMARK 465 SER C 160 REMARK 465 ASN C 177 REMARK 465 PHE C 178 REMARK 465 LYS C 179 REMARK 465 ASN C 180 REMARK 465 ASP C 181 REMARK 465 ASN C 182 REMARK 465 SER C 183 REMARK 465 HIS C 184 REMARK 465 TYR C 185 REMARK 465 ILE C 186 REMARK 465 ILE C 258 REMARK 465 ASN C 259 REMARK 465 GLN D 157 REMARK 465 ASN D 158 REMARK 465 GLY D 159 REMARK 465 SER D 160 REMARK 465 SER D 161 REMARK 465 TYR D 162 REMARK 465 ALA D 163 REMARK 465 PHE D 164 REMARK 465 ASP D 165 REMARK 465 THR D 166 REMARK 465 LYS D 167 REMARK 465 ASN D 177 REMARK 465 PHE D 178 REMARK 465 LYS D 179 REMARK 465 ASN D 180 REMARK 465 ASP D 181 REMARK 465 ASN D 182 REMARK 465 SER D 183 REMARK 465 HIS D 184 REMARK 465 TYR D 185 REMARK 465 ASN D 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 2 171.26 -58.85 REMARK 500 PRO A 22 172.77 -59.23 REMARK 500 ASN A 23 -91.87 -82.98 REMARK 500 ASN A 31 -117.96 40.41 REMARK 500 GLN A 32 44.37 -88.25 REMARK 500 LEU A 41 21.16 -140.16 REMARK 500 SER A 160 46.71 -91.47 REMARK 500 ASN A 226 99.27 -56.03 REMARK 500 PHE A 231 -54.59 -127.72 REMARK 500 ILE A 232 101.33 83.29 REMARK 500 ASN B 23 -70.97 -81.46 REMARK 500 ASN B 31 -120.96 36.96 REMARK 500 GLN B 32 43.27 -81.48 REMARK 500 ASP C 24 95.38 56.27 REMARK 500 ASN C 31 -124.52 43.18 REMARK 500 GLN C 32 42.06 -80.80 REMARK 500 PHE C 155 19.54 53.98 REMARK 500 HIS C 188 -114.08 60.72 REMARK 500 SER C 189 153.80 67.21 REMARK 500 LYS D 2 -94.62 -125.77 REMARK 500 ASN D 31 -122.21 36.29 REMARK 500 GLN D 32 44.59 -80.24 REMARK 500 LEU D 112 77.08 -103.84 REMARK 500 PRO D 213 -9.00 -58.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CSF C 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CSF C 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CSF C 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CSF C 4001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RO8 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CMP DBREF 1RO7 A 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 DBREF 1RO7 B 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 DBREF 1RO7 C 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 DBREF 1RO7 D 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 SEQADV 1RO7 MSE A 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO7 SER A 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO7 MSE A 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO7 MSE A 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQADV 1RO7 MSE B 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO7 SER B 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO7 MSE B 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO7 MSE B 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQADV 1RO7 MSE C 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO7 SER C 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO7 MSE C 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO7 MSE C 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQADV 1RO7 MSE D 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO7 SER D 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO7 MSE D 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO7 MSE D 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQRES 1 A 259 MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY PRO SER LEU SEQRES 2 A 259 LYS GLU ILE ASP TYR SER ARG LEU PRO ASN ASP PHE ASP SEQRES 3 A 259 VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU ASP LYS TYR SEQRES 4 A 259 TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE TYR ASN PRO SEQRES 5 A 259 SER LEU PHE PHE GLU GLN TYR TYR THR LEU LYS HIS LEU SEQRES 6 A 259 ILE GLN ASN GLN GLU TYR GLU THR GLU LEU ILE MSE CYS SEQRES 7 A 259 SER ASN TYR ASN GLN ALA HIS LEU GLU ASN GLU ASN PHE SEQRES 8 A 259 VAL LYS THR PHE TYR ASP TYR PHE PRO ASP ALA HIS LEU SEQRES 9 A 259 GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP PHE ASN ALA SEQRES 10 A 259 TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN GLN ARG ILE SEQRES 11 A 259 THR SER GLY VAL TYR MSE CYS ALA VAL ALA ILE ALA LEU SEQRES 12 A 259 GLY TYR LYS GLU ILE TYR LEU SER GLY ILE ASP PHE TYR SEQRES 13 A 259 GLN ASN GLY SER SER TYR ALA PHE ASP THR LYS GLN LYS SEQRES 14 A 259 ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS ASN ASP ASN SEQRES 15 A 259 SER HIS TYR ILE GLY HIS SER LYS ASN THR ASP ILE LYS SEQRES 16 A 259 ALA LEU GLU PHE LEU GLU LYS THR TYR LYS ILE LYS LEU SEQRES 17 A 259 TYR CYS LEU CYS PRO ASN SER LEU LEU ALA ASN PHE ILE SEQRES 18 A 259 GLU LEU ALA PRO ASN LEU ASN SER ASN PHE ILE ILE GLN SEQRES 19 A 259 GLU LYS ASN ASN TYR THR LYS ASP ILE LEU ILE PRO SER SEQRES 20 A 259 SER GLU ALA TYR GLY LYS PHE SER LYS ASN ILE ASN SEQRES 1 B 259 MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY PRO SER LEU SEQRES 2 B 259 LYS GLU ILE ASP TYR SER ARG LEU PRO ASN ASP PHE ASP SEQRES 3 B 259 VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU ASP LYS TYR SEQRES 4 B 259 TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE TYR ASN PRO SEQRES 5 B 259 SER LEU PHE PHE GLU GLN TYR TYR THR LEU LYS HIS LEU SEQRES 6 B 259 ILE GLN ASN GLN GLU TYR GLU THR GLU LEU ILE MSE CYS SEQRES 7 B 259 SER ASN TYR ASN GLN ALA HIS LEU GLU ASN GLU ASN PHE SEQRES 8 B 259 VAL LYS THR PHE TYR ASP TYR PHE PRO ASP ALA HIS LEU SEQRES 9 B 259 GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP PHE ASN ALA SEQRES 10 B 259 TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN GLN ARG ILE SEQRES 11 B 259 THR SER GLY VAL TYR MSE CYS ALA VAL ALA ILE ALA LEU SEQRES 12 B 259 GLY TYR LYS GLU ILE TYR LEU SER GLY ILE ASP PHE TYR SEQRES 13 B 259 GLN ASN GLY SER SER TYR ALA PHE ASP THR LYS GLN LYS SEQRES 14 B 259 ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS ASN ASP ASN SEQRES 15 B 259 SER HIS TYR ILE GLY HIS SER LYS ASN THR ASP ILE LYS SEQRES 16 B 259 ALA LEU GLU PHE LEU GLU LYS THR TYR LYS ILE LYS LEU SEQRES 17 B 259 TYR CYS LEU CYS PRO ASN SER LEU LEU ALA ASN PHE ILE SEQRES 18 B 259 GLU LEU ALA PRO ASN LEU ASN SER ASN PHE ILE ILE GLN SEQRES 19 B 259 GLU LYS ASN ASN TYR THR LYS ASP ILE LEU ILE PRO SER SEQRES 20 B 259 SER GLU ALA TYR GLY LYS PHE SER LYS ASN ILE ASN SEQRES 1 C 259 MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY PRO SER LEU SEQRES 2 C 259 LYS GLU ILE ASP TYR SER ARG LEU PRO ASN ASP PHE ASP SEQRES 3 C 259 VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU ASP LYS TYR SEQRES 4 C 259 TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE TYR ASN PRO SEQRES 5 C 259 SER LEU PHE PHE GLU GLN TYR TYR THR LEU LYS HIS LEU SEQRES 6 C 259 ILE GLN ASN GLN GLU TYR GLU THR GLU LEU ILE MSE CYS SEQRES 7 C 259 SER ASN TYR ASN GLN ALA HIS LEU GLU ASN GLU ASN PHE SEQRES 8 C 259 VAL LYS THR PHE TYR ASP TYR PHE PRO ASP ALA HIS LEU SEQRES 9 C 259 GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP PHE ASN ALA SEQRES 10 C 259 TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN GLN ARG ILE SEQRES 11 C 259 THR SER GLY VAL TYR MSE CYS ALA VAL ALA ILE ALA LEU SEQRES 12 C 259 GLY TYR LYS GLU ILE TYR LEU SER GLY ILE ASP PHE TYR SEQRES 13 C 259 GLN ASN GLY SER SER TYR ALA PHE ASP THR LYS GLN LYS SEQRES 14 C 259 ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS ASN ASP ASN SEQRES 15 C 259 SER HIS TYR ILE GLY HIS SER LYS ASN THR ASP ILE LYS SEQRES 16 C 259 ALA LEU GLU PHE LEU GLU LYS THR TYR LYS ILE LYS LEU SEQRES 17 C 259 TYR CYS LEU CYS PRO ASN SER LEU LEU ALA ASN PHE ILE SEQRES 18 C 259 GLU LEU ALA PRO ASN LEU ASN SER ASN PHE ILE ILE GLN SEQRES 19 C 259 GLU LYS ASN ASN TYR THR LYS ASP ILE LEU ILE PRO SER SEQRES 20 C 259 SER GLU ALA TYR GLY LYS PHE SER LYS ASN ILE ASN SEQRES 1 D 259 MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY PRO SER LEU SEQRES 2 D 259 LYS GLU ILE ASP TYR SER ARG LEU PRO ASN ASP PHE ASP SEQRES 3 D 259 VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU ASP LYS TYR SEQRES 4 D 259 TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE TYR ASN PRO SEQRES 5 D 259 SER LEU PHE PHE GLU GLN TYR TYR THR LEU LYS HIS LEU SEQRES 6 D 259 ILE GLN ASN GLN GLU TYR GLU THR GLU LEU ILE MSE CYS SEQRES 7 D 259 SER ASN TYR ASN GLN ALA HIS LEU GLU ASN GLU ASN PHE SEQRES 8 D 259 VAL LYS THR PHE TYR ASP TYR PHE PRO ASP ALA HIS LEU SEQRES 9 D 259 GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP PHE ASN ALA SEQRES 10 D 259 TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN GLN ARG ILE SEQRES 11 D 259 THR SER GLY VAL TYR MSE CYS ALA VAL ALA ILE ALA LEU SEQRES 12 D 259 GLY TYR LYS GLU ILE TYR LEU SER GLY ILE ASP PHE TYR SEQRES 13 D 259 GLN ASN GLY SER SER TYR ALA PHE ASP THR LYS GLN LYS SEQRES 14 D 259 ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS ASN ASP ASN SEQRES 15 D 259 SER HIS TYR ILE GLY HIS SER LYS ASN THR ASP ILE LYS SEQRES 16 D 259 ALA LEU GLU PHE LEU GLU LYS THR TYR LYS ILE LYS LEU SEQRES 17 D 259 TYR CYS LEU CYS PRO ASN SER LEU LEU ALA ASN PHE ILE SEQRES 18 D 259 GLU LEU ALA PRO ASN LEU ASN SER ASN PHE ILE ILE GLN SEQRES 19 D 259 GLU LYS ASN ASN TYR THR LYS ASP ILE LEU ILE PRO SER SEQRES 20 D 259 SER GLU ALA TYR GLY LYS PHE SER LYS ASN ILE ASN MODRES 1RO7 MSE A 1 MET SELENOMETHIONINE MODRES 1RO7 MSE A 77 MET SELENOMETHIONINE MODRES 1RO7 MSE A 136 MET SELENOMETHIONINE MODRES 1RO7 MSE B 1 MET SELENOMETHIONINE MODRES 1RO7 MSE B 77 MET SELENOMETHIONINE MODRES 1RO7 MSE B 136 MET SELENOMETHIONINE MODRES 1RO7 MSE C 1 MET SELENOMETHIONINE MODRES 1RO7 MSE C 77 MET SELENOMETHIONINE MODRES 1RO7 MSE C 136 MET SELENOMETHIONINE MODRES 1RO7 MSE D 1 MET SELENOMETHIONINE MODRES 1RO7 MSE D 77 MET SELENOMETHIONINE MODRES 1RO7 MSE D 136 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 77 8 HET MSE A 136 8 HET MSE B 1 8 HET MSE B 77 8 HET MSE B 136 8 HET MSE C 1 8 HET MSE C 77 8 HET MSE C 136 8 HET MSE D 1 8 HET MSE D 77 8 HET MSE D 136 8 HET MPD B 401 8 HET CSF C1001 42 HET CSF C2001 42 HET CSF C3001 42 HET CSF C4001 42 HETNAM MSE SELENOMETHIONINE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM CSF CYTIDINE-5'-MONOPHOSPHATE-3-FLUORO-N-ACETYL-NEURAMINIC HETNAM 2 CSF ACID HETSYN CSF CMP-3FNEUAC FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 5 MPD C6 H14 O2 FORMUL 6 CSF 4(C20 H30 F N4 O16 P) FORMUL 10 HOH *330(H2 O) HELIX 1 1 GLY A 10 GLU A 15 5 6 HELIX 2 2 GLN A 32 GLU A 36 5 5 HELIX 3 3 ASN A 51 SER A 53 5 3 HELIX 4 4 LEU A 54 ASN A 68 1 15 HELIX 5 5 ASN A 88 THR A 94 1 7 HELIX 6 6 THR A 94 PHE A 99 1 6 HELIX 7 7 GLY A 105 LYS A 110 1 6 HELIX 8 8 LEU A 112 ASN A 127 1 16 HELIX 9 9 THR A 131 GLY A 144 1 14 HELIX 10 10 GLN A 168 ALA A 175 1 8 HELIX 11 11 PRO A 176 ASN A 180 5 5 HELIX 12 12 SER A 189 LYS A 205 1 17 HELIX 13 13 SER A 215 PHE A 220 5 6 HELIX 14 14 SER A 247 SER A 255 1 9 HELIX 15 15 LYS A 256 ILE A 258 5 3 HELIX 16 16 GLY B 10 ILE B 16 5 7 HELIX 17 17 ASP B 17 LEU B 21 5 5 HELIX 18 18 GLN B 32 GLU B 36 5 5 HELIX 19 19 ASN B 51 SER B 53 5 3 HELIX 20 20 LEU B 54 ASN B 68 1 15 HELIX 21 21 ASN B 88 PHE B 99 1 12 HELIX 22 22 GLY B 105 LYS B 110 1 6 HELIX 23 23 LEU B 112 ASN B 127 1 16 HELIX 24 24 THR B 131 LEU B 143 1 13 HELIX 25 25 GLN B 168 ALA B 175 1 8 HELIX 26 26 SER B 189 TYR B 204 1 16 HELIX 27 27 SER B 215 PHE B 220 5 6 HELIX 28 28 SER B 247 SER B 255 1 9 HELIX 29 29 LYS B 256 ILE B 258 5 3 HELIX 30 30 GLY C 10 ILE C 16 5 7 HELIX 31 31 ASP C 17 LEU C 21 5 5 HELIX 32 32 GLN C 32 GLU C 36 5 5 HELIX 33 33 ASN C 51 SER C 53 5 3 HELIX 34 34 LEU C 54 ASN C 68 1 15 HELIX 35 35 ASN C 88 PHE C 99 1 12 HELIX 36 36 GLY C 105 LYS C 110 1 6 HELIX 37 37 LEU C 112 ASN C 127 1 16 HELIX 38 38 THR C 131 LEU C 143 1 13 HELIX 39 39 GLN C 168 ALA C 175 1 8 HELIX 40 40 SER C 189 LYS C 205 1 17 HELIX 41 41 SER C 215 PHE C 220 5 6 HELIX 42 42 SER C 247 SER C 255 1 9 HELIX 43 43 GLY D 10 ILE D 16 5 7 HELIX 44 44 ASP D 17 LEU D 21 5 5 HELIX 45 45 GLN D 32 GLU D 36 5 5 HELIX 46 46 ASN D 51 SER D 53 5 3 HELIX 47 47 LEU D 54 ASN D 68 1 15 HELIX 48 48 ASN D 88 PHE D 99 1 12 HELIX 49 49 GLY D 105 LYS D 110 1 6 HELIX 50 50 LEU D 112 ASN D 127 1 16 HELIX 51 51 THR D 131 GLY D 144 1 14 HELIX 52 52 GLN D 168 ALA D 175 1 8 HELIX 53 53 SER D 189 LYS D 205 1 17 HELIX 54 54 SER D 215 PHE D 220 5 6 HELIX 55 55 SER D 247 SER D 255 1 9 HELIX 56 56 LYS D 256 ILE D 258 5 3 SHEET 1 A 7 HIS A 103 LEU A 104 0 SHEET 2 A 7 GLU A 72 CYS A 78 1 N ILE A 76 O HIS A 103 SHEET 3 A 7 LYS A 44 TYR A 50 1 N VAL A 48 O MSE A 77 SHEET 4 A 7 PHE A 25 CYS A 30 1 N VAL A 27 O LYS A 46 SHEET 5 A 7 LYS A 3 ALA A 7 1 N ILE A 5 O ASP A 26 SHEET 6 A 7 GLU A 147 SER A 151 1 O TYR A 149 N VAL A 4 SHEET 7 A 7 LYS A 207 CYS A 210 1 O TYR A 209 N LEU A 150 SHEET 1 B 2 LYS A 38 TYR A 39 0 SHEET 2 B 2 GLN A 234 GLU A 235 -1 O GLN A 234 N TYR A 39 SHEET 1 C 7 HIS B 103 LEU B 104 0 SHEET 2 C 7 GLU B 72 CYS B 78 1 N ILE B 76 O HIS B 103 SHEET 3 C 7 LYS B 44 TYR B 50 1 N VAL B 48 O MSE B 77 SHEET 4 C 7 PHE B 25 CYS B 30 1 N VAL B 27 O LYS B 46 SHEET 5 C 7 LYS B 3 ALA B 7 1 N ILE B 5 O ASP B 26 SHEET 6 C 7 GLU B 147 SER B 151 1 O TYR B 149 N VAL B 4 SHEET 7 C 7 LYS B 207 CYS B 210 1 O TYR B 209 N LEU B 150 SHEET 1 D 7 HIS C 103 LEU C 104 0 SHEET 2 D 7 GLU C 72 CYS C 78 1 N ILE C 76 O HIS C 103 SHEET 3 D 7 LYS C 44 TYR C 50 1 N VAL C 48 O MSE C 77 SHEET 4 D 7 PHE C 25 CYS C 30 1 N VAL C 27 O LYS C 46 SHEET 5 D 7 LYS C 3 ALA C 7 1 N ILE C 5 O ASP C 26 SHEET 6 D 7 GLU C 147 SER C 151 1 O TYR C 149 N ILE C 6 SHEET 7 D 7 LYS C 207 CYS C 210 1 O TYR C 209 N LEU C 150 SHEET 1 E 2 LYS C 38 TYR C 39 0 SHEET 2 E 2 GLN C 234 GLU C 235 -1 O GLN C 234 N TYR C 39 SHEET 1 F 7 HIS D 103 LEU D 104 0 SHEET 2 F 7 GLU D 72 CYS D 78 1 N ILE D 76 O HIS D 103 SHEET 3 F 7 LYS D 44 TYR D 50 1 N CYS D 45 O GLU D 72 SHEET 4 F 7 ASP D 26 CYS D 30 1 N VAL D 27 O LYS D 46 SHEET 5 F 7 LYS D 3 ALA D 7 1 N ILE D 5 O ASP D 26 SHEET 6 F 7 GLU D 147 SER D 151 1 O TYR D 149 N VAL D 4 SHEET 7 F 7 LYS D 207 CYS D 210 1 O TYR D 209 N LEU D 150 SHEET 1 G 2 LYS D 38 TYR D 39 0 SHEET 2 G 2 GLN D 234 GLU D 235 -1 O GLN D 234 N TYR D 39 LINK C MSE A 1 N LYS A 2 1555 1555 1.33 LINK C ILE A 76 N MSE A 77 1555 1555 1.33 LINK C MSE A 77 N CYS A 78 1555 1555 1.33 LINK C TYR A 135 N MSE A 136 1555 1555 1.33 LINK C MSE A 136 N CYS A 137 1555 1555 1.33 LINK C MSE B 1 N LYS B 2 1555 1555 1.33 LINK C ILE B 76 N MSE B 77 1555 1555 1.33 LINK C MSE B 77 N CYS B 78 1555 1555 1.33 LINK C TYR B 135 N MSE B 136 1555 1555 1.33 LINK C MSE B 136 N CYS B 137 1555 1555 1.33 LINK C MSE C 1 N LYS C 2 1555 1555 1.33 LINK C ILE C 76 N MSE C 77 1555 1555 1.33 LINK C MSE C 77 N CYS C 78 1555 1555 1.33 LINK C TYR C 135 N MSE C 136 1555 1555 1.33 LINK C MSE C 136 N CYS C 137 1555 1555 1.33 LINK C MSE D 1 N LYS D 2 1555 1555 1.33 LINK C ILE D 76 N MSE D 77 1555 1555 1.33 LINK C MSE D 77 N CYS D 78 1555 1555 1.33 LINK C TYR D 135 N MSE D 136 1555 1555 1.33 LINK C MSE D 136 N CYS D 137 1555 1555 1.33 SITE 1 AC1 29 GLY A 8 ASN A 9 GLY A 10 CYS A 30 SITE 2 AC1 29 ASN A 31 GLN A 32 ASN A 51 LEU A 54 SITE 3 AC1 29 GLN A 58 THR A 131 SER A 132 GLY A 133 SITE 4 AC1 29 GLY A 152 ILE A 153 ASP A 154 PHE A 155 SITE 5 AC1 29 TYR A 156 GLY A 159 SER A 161 TYR A 162 SITE 6 AC1 29 PHE A 178 TYR A 185 HIS A 188 HOH A 262 SITE 7 AC1 29 HOH A 313 HOH A 326 HOH C4007 HOH C4050 SITE 8 AC1 29 HOH C4081 SITE 1 AC2 20 GLY B 8 ASN B 9 GLY B 10 CYS B 30 SITE 2 AC2 20 ASN B 31 GLN B 32 ASN B 51 LEU B 54 SITE 3 AC2 20 GLN B 58 THR B 131 SER B 132 GLY B 133 SITE 4 AC2 20 GLY B 152 ILE B 153 ASP B 154 PHE B 155 SITE 5 AC2 20 PHE B 178 HIS B 188 HOH B 436 HOH C4005 SITE 1 AC3 23 GLY C 8 ASN C 9 GLY C 10 CYS C 30 SITE 2 AC3 23 ASN C 31 GLN C 32 ASN C 51 LEU C 54 SITE 3 AC3 23 GLN C 58 THR C 131 SER C 132 GLY C 133 SITE 4 AC3 23 GLY C 152 ILE C 153 ASP C 154 PHE C 155 SITE 5 AC3 23 TYR C 156 SER C 161 TYR C 162 HIS C 188 SITE 6 AC3 23 HOH C4014 HOH C4027 HOH C4082 SITE 1 AC4 16 GLY D 8 ASN D 9 GLY D 10 ASN D 31 SITE 2 AC4 16 GLN D 32 ASN D 51 LEU D 54 THR D 131 SITE 3 AC4 16 SER D 132 GLY D 152 ILE D 153 ASP D 154 SITE 4 AC4 16 PHE D 155 TYR D 156 HIS D 188 HOH D 272 CRYST1 83.660 66.031 99.172 90.00 94.42 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011953 0.000000 0.000924 0.00000 SCALE2 0.000000 0.015144 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010114 0.00000